Preview Mode Links will not work in preview mode
  1. All Episodes
  2. Ovarian Cancer | Consensus or Controversy? Current and Future Management of Ovarian Cancer

Ovarian Cancer | Consensus or Controversy? Current and Future Management of Ovarian Cancer

Nov 30, 2022

Featuring perspectives from Drs Ursula Matulonis and Debra Richardson, including the following topics:

  • PROLOGUE: Antibody-Drug Conjugates Across Oncology (0:00)
  • Antibody-Drug Conjugates in Ovarian Cancer: Mirvetuximab Soravtansine (10:03)
  • Antibody-Drug Conjugates in Ovarian Cancer: Upifitamab Rilsodotin (29:09)
  • Tumor Treating Fields (41:35)
  • PARP Inhibitor Update (47:29)

CME information and select publications